Irwindeep Sandhu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Future oncology (London, England)

Current oncology (Toronto, Ont.)

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Justine Lai, Chuquan Shang, Will Chen, Iyare Izevbaye, Michael P Chu, Irwindeep Sandhu, Joseph Brandwein, Raymond Lai, Peng Wang
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. International journal of molecular sciences 25 (1) (2023)
Justine Lai, Chuquan Shang, Will Chen, Iyare Izevbaye, Michael P Chu, Irwindeep Sandhu, Joseph Brandwein, Raymond Lai, Peng Wang
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. International journal of molecular sciences 25 (1) (2023)
Bethany E Monteith, Irwindeep Sandhu, Ann S Lee
Management of Multiple Myeloma: A Review for General Practitioners in Oncology. Current oncology (Toronto, Ont.) 30 (5) (2023)
Justine Lai, Chuquan Shang, Will Chen, Iyare Izevbaye, Michael P Chu, Irwindeep Sandhu, Joseph Brandwein, Raymond Lai, Peng Wang
An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter. International journal of molecular sciences 25 (1) (2023)
Barry A Paul, Michaela Liedtke, Jack Khouri, Robert M Rifkin, Mitul D Gandhi, Andrew Kin, Moshe Y Levy, Rebecca W Silbermann, Francesca Cottini, Douglas W Sborov, Irwindeep Sandhu, Lyssa Villarreal, Michael Murphy, Lin Gu, Ann Chen, Nishanthan Rajakumaraswamy, Saad Z Usmani
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma. Future oncology (London, England) (2023)
Hartmut Döhner, Andrew H Wei, Gail J Roboz, Pau Montesinos, Felicitas R Thol, Farhad Ravandi, Hervé Dombret, Kimmo Porkka, Irwindeep Sandhu, Barry Skikne, Wendy L See, Manuel Ugidos, Alberto Risueño, Esther T Chan, Anjan Thakurta, C L Beach, Daniel Lopes de Menezes
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine. Blood 140 (15) (2022)
Paul Gerard Richardson, Shaji K Kumar, Tamás Masszi, Norbert Grzasko, Nizar J Bahlis, Markus Hansson, Luděk Pour, Irwindeep Sandhu, Peter Ganly, Bartrum W Baker, Sharon R Jackson, Anne-Marie Stoppa, Peter Gimsing, Laurent Garderet, Cyrille Touzeau, Francis K Buadi, Jacob P Laubach, Michele Cavo, Mohamed Darif, Richard Labotka, Deborah Berg, Philippe Moreau
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)